Cargo Therapeutics Stock (NASDAQ: CRGX) stock price, news, charts, stock research, profile.
Open | $20.830 |
Close | - |
Volume / Avg. | 6.186K / 309.410K |
Day Range | 20.810 - 21.230 |
52 Wk Range | 13.140 - 33.920 |
Market Cap | $830.088M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 10.9% |
Days to Cover | 20.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cargo Therapeutics (NASDAQ: CRGX) through any online brokerage.
Other companies in Cargo Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA) and Zentalis Pharma (NASDAQ:ZNTL).
The latest price target for Cargo Therapeutics (NASDAQ: CRGX) was reported by Truist Securities on Thursday, May 16, 2024. The analyst firm set a price target for 32.00 expecting CRGX to rise to within 12 months (a possible 51.77% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Cargo Therapeutics (NASDAQ: CRGX) is $21.085 last updated Today at May 16, 2024 at 10:27 AM EDT.
There are no upcoming dividends for Cargo Therapeutics.
Cargo Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Cargo Therapeutics.
Cargo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.